Red blood cell products and compositions are disclosed. The product includes a container made from PVC or a non-PVC material that is substantially free of a phthalate plasticizer but otherwise includes one or more non-phthalate plasticizers or extractable agents. The product includes a RBC concentrate which has been combined with an additive solution for storing the RBCs.

A transfer device includes a transfer device body, the transfer device body includes a carrying plate and a picking-up plate. The picking-up plate is configured to drive the carrying plate to move, and a first end of the picking-up plate is fixedly connected to a first edge portion of the carrying plate. The carrying plate is configured to pick up and carry an object to be transplanted.

The invention relates to a medical device in the form of a cartridge (2) incorporating an assembly permitting the preservation of corneal tissue that has been obtained beforehand by sampling, the device comprising: a storage compartment (24) containing a preserving fluid, at least one input terminal (21) upstream from the storage compartment (24), for injecting a compressed pressurizing gas, at least one control terminal (22) upstream from the storage compartment (24), for injecting a compressed control gas, a pneumatically controlled switching system (26) downstream from the terminals (21, 22), said switching system (26) being controlled by the compressed control gas in order to permit or prohibit the circulation of the compressed pressurizing gas towards the storage compartment (24).

A device and method for preserving corneal graft tissue. In one embodiment, a device for preserving corneal graft tissue comprises: a first chamber; a second chamber; and a corneal graft tissue suspension assembly that is configured to retain and suspend the corneal graft tissue between the first chamber and the second chamber, the first chamber being fluidly isolated from the second chamber when the corneal graft tissue is graft tissue is retained and suspended within the corneal graft tissue suspension assembly. In one embodiment, a method includes filling a first chamber of a device with a first preservation medium and filling a second chamber of the device with a second preservation medium different than or the same as the first, a corneal graft tissue being located between the first and second chambers.

A shock absorbing device to protect cryogenically frozen biological material includes an outer sleeve and a foam sleeve. The outer sleeve defines an interior volume and has an opening configured to pass a biological material container into the interior volume. The foam sleeve is in the interior volume and has an opening and an interior cavity. The opening of the foam sleeve is aligned with the opening of the outer sleeve to pass the biological material container into the interior cavity. In another embodiment, the shock absorbing device includes a first layer, a foam layer, and a liner layer to retain the foam layer. A first side of the foam layer is adjacent and facing a second side of the first layer. A first side of the liner layer is adjacent and facing a second side of the foam layer.

An organ container has a contractible and expandable pouch-shaped body having an opening. Under no-load conditions, the opening has a maximum width smaller than a maximum width of the body. The opening is expandable up to a state in which the maximum width of the opening is greater than the maximum width of the body. The body has an inner surface that includes a first region having a smooth curved surface and a second region having an uneven shape. The uneven shape of the inner surface of the body allows a preservation solution to protrude into interstices between an organ and the inner surface and thereby improves a thermal insulating effect. Moreover, by providing the smooth first region, generation of remaining traces can be suppressed. Accordingly, it is possible to effectively suppress a temperature rise in the organ and to reduce damage to the organ.

A shock absorbing container to protect cryogenically frozen biological material includes an outer case, which includes a first outer panel and a second outer panel, the first outer panel and the second outer panel movable relative to each other between a closed position and an open position, the first outer panel and the second outer panel defining a storage space in the closed position, the first outer panel having a first side facing the storage space, the second outer panel having a first side facing the storage space, wherein moving the first outer panel and the second outer panel into the open position creates or enlarges an opening to access the storage space. A first foam panel is on the first side of the first outer panel, and a second foam panel on the first side of the second outer panel.

A holding tool is configured to efficiently and reliably enable a close contact between a container and a lid with a simple mechanism and a simple operation. The holding tool is configured to be used together with a container and a lid for the container to sandwich the container and the lid. The holding tool includes a base on which the container is placed, and a cover configured to cover the lid. The base and the cover each have an opening at a central portion and are configured to engage with each other to press and sandwich the container and the lid upward and downward.

Dosage units consist of an autologous cell therapy product composed of fibroblasts grown for each individual to be treated for augmentation or regeneration of vocal cords. The suspension of autologous fibroblasts, grown from a biopsy of each individual's own buccal mucosa or skin using current good manufacturing practices (CGMP) and standard tissue culture procedures, is supplied in vials containing cryopreserved fibroblasts or precursors thereof, having a purity of at least 98% fibroblasts and a viability of at least 85%, for administration of from one to six mL, preferably two mL administered three times approximately three to six weeks apart, of cells at a concentration of from 1.0-2.0×10.sup.7 cells/mL.

An apparatus for perfusing an organ or tissue including a perfusion circuit for perfusing the organ or tissue with liquid perfusate; and an oxygenation system for oxygenating perfusate that recirculates through the perfusion circuit. The oxygenation system includes an oxygen circuit for delivering oxygen to the liquid perfusate and an air circuit for delivering ambient air to the liquid perfusate. The air may be pumped through the oxygenation system via an air pump. The air or oxygen may be bubble through the perfusate to increase oxygen levels in the perfusate. Such supplemental oxygen may beneficial during hypothermic preservation of organs.